Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Most recent entries » Horizons in World Cardiovascular Research. Volume 2 Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Nanofiltration: Applications, Advancements and Research
$82.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27
Tell A Friend
 
Tell someone you know about this product.
Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27 $100.00
Authors:  (Yuliy Y. Chirkov, Aaron L. Sverdlov, John D. Horowitz, Basil Hetzel Institute, The Queen Elizabeth Hospital/Dept. of Medicine, The University of Adelaide, Australia)
Abstract:
Perhexiline, 2-(2,2-dicyclohexylethyl)piperidine, was originally developed as a prophylactic anti-anginal drug in the late 1960s. It was initially a popular and effective treatment for angina, having the almost unique property compared to other agents available at that time, of not inducing reductions in blood pressure or heart rate. Despite the initial success, its use diminished markedly due to the occurrence during long-term therapy of poorly understood side effects (neurotoxicity and hepatotoxicity), which later were shown to be associated with high plasma concentrations of perhexiline, occurring in patients with relatively slow hepatic metabolism of the drug. However, therapeutic plasma monitoring and associated dose adjustments have led to perhexiline's reintroduction into clinical practice. Recent clinical data have proved its safety and
maintained efficacy. Perhexiline reduced anginal frequency in patients with refractory angina. In patients with chronic heart failure, perhexiline improved peak exercise oxygen consumption, left ventricular ejection fraction, symptoms, resting and peak stress
myocardial function. Perhexiline also appears to be effective in suppressing symptoms in patients with acute coronary syndromes or with advanced and inoperable aortic valvular stenosis. Herein we discuss perhexiline's pharmacology with particular emphasis on its
mechanism(s) of action. 


Available Options:
Version:
Special Focus Titles
01.The Bronze Mask: Protagonists of English Literature
02.Biotechnological Applications of Seaweeds
03.The Lonely Ape that Told Himself Stories: The Necessity of Stories for Human Survival
04.Different Aspects on Chemotherapy of Trypanosomatids
05.Pediatric Surgery Handbook for Residents and Medical Students
06.Fighting for a Gender[ed] Identity: An Ethnographic Examination of White Collar Boxers
07.Blood Viscosity: Its Role in Cardiovascular Pathophysiology and Hematology
08.Neonatal and Perinatal Mortality: Global Challenges, Risk Factors and Interventions
09.Trichotillomania (Hair Pulling Disorder): Clinical Characteristics, Psychological Interventions and Emotional Effects
10.Thyroid Nodules and Cancer: A Simplified Case Oriented Approach
11.Biliary Diseases with Pancreatic Counterparts: A New Disease Concept
12.SAFETY & PERFORMANCE
Total Respect Management (TR3M): A Novel Approach to Achieve Safety and Performance Proactively in Any Organisation

Nova Science Publishers
© Copyright 2004 - 2017

Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27